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performed at the same time under local anaesthesia. The
use of the new tined lead electrode significantly increased
the success rate for the screening phase. 
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Introduction
Sacral nerve stimulation (SNS) is an amazing therapy
option for patients with urinary and bowel dysfunction
[1–6]. The procedure involves three stages. The first step is
a percutaneous nerve evaluation with a foramen needle. If a
contraction of the pelvic floor can be observed, the second
step consists of introducing a test electrode and an external
pulse generator for a screening phase of 10–14 days. In
patients with a positive response (symptoms decrease of
more than 50% measured by a continence diary), the third
step replaces the test electrode with a permanent electrode,
and a definitive implantation of the “internal pulse genera-
tor” (IPG) can be performed [1, 7].
However, the technique of SNS for the treatment of fae-
cal incontinence is not standardised yet. Due to a high
migration rate of test electrodes and due to the invasiveness
of open implantation of the permanent system [8], Spinelli
et al. [9], and the manufacture of the stimulator (Medtronic,
Minneapolis, USA) recently developed a transcutaneous
electrode (tined lead electrode) and a minimally invasive
introducing kit. The new transcutaneous system is designed
as a permanent electrode and can be used for both screen-
ing and permanent stimulation. It is supposed to improve
the success rate of screening by decreasing the risk of elec-
trode migration. In addition, implantation of the new tined
lead electrode can be performed under local anaesthesia.
Thereafter, the patient can feel and localise the stimulation
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Abstract Background The purpose of this study was to
assess the influence of the type of anaesthesia (local vs.
general) and of the electrode used (test electrode vs. tined
lead) on a successful screening period. Methods Between
May 2001 and January 2004, we performed 25 percuta-
neous nerve evaluation (PNE) tests in 20 patients (11
women). The first 15 PNE tests were followed by intro-
ducing a conventional electrode, and since 2003 by a tined
lead electrode. Success was defined as reduction of symp-
toms by more than 50%. Results A stimulator was
implanted in 13 (68%) patients, including 4 of 14 screened
with the conventional electrode and 9 of 10 screened with
tined lead electrode (p=0.005). Eleven (44%) of the PNE
tests were done under local anaesthesia, but the success
rate was not influenced by the type of anaesthesia (local
46% vs. general 61%, p=0.682). Conclusions PNE testing
and implantation of the tined lead electrode can be easily
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during the procedure, thus increasing the accuracy of sacral
stimulation, which eases the procedure. 
Today, most centres favour a combination of percuta-
neous nerve evaluation with primary implantation of test
electrodes. After successful screening, those test elec-
trodes have to be replaced by permanent electrode (two
step procedure). The permanent implantation is performed
through a presacral incision under general anaesthesia. 
The aims of this study were to assess the influence of
the type of electrode used (conventional test electrode vs.
new tined lead electrode) and the type of anaesthesia (local
anaesthesia vs. general anaesthesia) on success of the SNS
screening test.
Patients and methods
Between May 2001 and January 2004, we performed 25 percuta-
neous nerve evaluation tests in 20 patients (11 women) with faecal
incontinence of median age 63 years (range, 33–86). The aetiolo-
gy of incontinence was idiopathic in 5 patients, obstetrical injury
(n=4), after low anterior rectum resection (n=3), residual Guillain-
Barrré polyneuritis (n=2), and in 1 case each after repair of com-
plete external rectal prolapse, multiple sclerosis, spinal trauma,
anal atresia, radiochemotherapy for anal carcinoma and subse-
quent to haemorrhoidectomy. These patients remained faecally
incontinent despite of medical treatment and biofeedback therapy.
All patients had persisting symptoms within the last 12 months.
Evaluation tests gave a positive response in 24 of 25 cases, and
were followed by a screening phase. For the screening, a conven-
tional test electrode was implanted 14 times, and since January 2003
the new tined lead electrode used for 10 screenings. Fifteen interven-
tions were done as day-case procedure (<12 hours hospital stay) and
10 patients were hospitalised overnight (<36 hours hospital stay).
There was no significant difference in type and severity of
incontinence for the two types of electrodes used in the evaluation
test. Patients with conventional test electrode had a median
Wexner score of 13.5 (range, 8–16) and those with tined lead 15
(range, 6–20); p=0.553. All patients received single dose antibi-
otics preoperatively (1000 mg cefazolin and 500 mg metronidazole
intravenously). Wexner score and a daily diary were used to assess
continence preoperatively, during the screening phase (10–14
days) and up to one month after implantation of the permanent sys-
tem. All patients underwent a thorough clinical investigation,
including colonoscopy, anal endosonography and anorectal physi-
ology. The results of the preoperative anal manometry and rectal
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sensation tests are shown in Table 1. Success was defined as a
reduction in the number of incontinence episodes or days and, for
the urge incontinence group, as a decrease of voiding frequency by
more than 50% during the screening phase. 
Surgical technique
Percutaneous nerve evaluation was performed with the patient in
prone position using an insulated foramen needle (model 141828;
Medtronic, Minneapolis, USA) in all patients. The procedure was
done either under local or general anaesthesia without any
curarization to assess the responses to electrostimulation. The
best response of S3 to S4 was tested on both sides. 
Immediately after the observation of pelvic floor contraction,
a temporary conventional test electrode (model 30576SC;
Medtronic) or a new tined lead (model 3889, Medtronic) (Fig. 1)
was inserted. The conventional electrode was fixed at the skin
level and connected through the extension (model 41827,
Medtronic) to the external impulse generator (Screener model
3625, Medtronic). A neutral electrode (model 41826, Medtronic)
usually placed on the abdomen skin was necessary for this set-
ting. The tined lead electrode was introduced in Seldinger tech-
nique over a guide wire through an introducer and the exact posi-
tion of the electrode tip was checked by laterolateral pelvic fluo-
roscopy. In case of positive response, the proximal part of the
tined lead electrode (Fig. 1) and the extension (model 3550–05,
Medtronic) were tunnelled and connected to a screening cable
(model 3550–03, Medtronic) and to the external pulse generator. 
The stimulation parameters were identical for patients in both
groups: pulse width, 210 µs; frequency, 15 Hz; amplitude adapt-
able by the patients (limited range, 0–10 V).
Permanent implantation took place immediately after the
screening period. At the beginning of the study, the conventional
test electrode had to be removed and in the same place the perma-
nent electrode (model 3080, Medtronic) was implanted in an open
way and sutured to the fascia of the sacrum in 5 patients [10, 11].
The internal stimulator IPG (InterStim model 3023, Medtronic)
was placed in a subcutaneous pocket made on the opposite gluteal
region of the implanted electrode and connected to the electrode.
In patients who had a successful screening with the tined lead elec-
trode, the transcutaneous screening cable was removed and the
stimulator IPG was directly connected in the same manner.
Results were documented by their median values as well their
minima and maxima. Statistical analysis for the type of elec-
trodes was performed with the Mann-Whitney test. To compare
the pre- and postoperative incontinence scores, Wilcoxon’s
paired rank sum test was used.
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Table 1 Results of preoperative anal manometry and rectal sensation in 19 screened patients with faecal incontinence. Values are median (range)
Conventional test electrode Tined lead electrode p
Resting pressure (normal, >40 mmHg) 30 (12–60) 38 (10–50) 0.877
Squeeze pressure increment (normal, >50 mmHg) 35 (0–100) 40 (20–50) 0.756
Threshold volume (normal, <30 ml air) 35 (30–200) 28 (15–30) 0.023
Urge volume (normal, 150±20 ml air) 90 (50–120) 55 (30–70) 0.086
Maximum tolerated volume (normal, 150±20 ml air) 125 (60–170) 125 (60–180) 0.864
Results
A total of 24 screening electrodes were placed in 19
patients depending on the best pelvic floor response
observed intraoperatively. The conventional electrode was
introduced in the sacral foramen S3 in 13 and in S4 in 2
evaluations tests; the tined lead electrode was placed in S3
in 7 cases and in S4 in 2 cases. In one case of spinal trau-
ma with neurological faecal incontinence, the percuta-
neous nerve evaluation did not induce any pelvic floor
contraction and the screening phase was cancelled. Types
of implanted electrodes and results of the screening are
summarised in Table 2.
Nine patients had a primary successful screening result
and 3 needed a second screening period before permanent
stimulator was implanted. In one patient, a third screening
was performed 12 months after insufficient unilateral per-
manent stimulation. This third screening was performed
with a tined lead electrode and a bilateral twin stimulator
was then implanted. 
Dislocation of the electrode during the screening
period was responsible for 7 screening failures (50%) in
the conventional electrode group and for one failure
(10%) in the tined lead electrode group (p=0.79). Four of
14 screenings with conventional test electrode and 9 of
10 screenings with tined lead electrodes received perma-
nent stimulation (p=0.005). Overall the permanent stim-
ulator was implanted in 13 of 19 patients (68%), with a
median follow-up of 13 months (range, 5–33 months).
Infection of electrodes did not occur in either group. One
patient required a surgical revision of the IPG pocket
due to a seroma.
Of all percutaneous nerve evaluation and screening
procedures, 11 (44%) were done under local anaesthesia.
All were subjectively and objectively well tolerated (no
additional analgesia was necessary). Success of the percu-
taneous nerve evaluation test and success of definitive
implantation were not influenced by the type of anaesthe-
sia (local 46% vs. general 61%, respectively; p=0.682).
For all but five patients, the number of episodes of fae-
cal incontinence per week decreased from a median of 6
(range, 0–31) to 2 (range, 0–8) (p=0.009) during screening
phase. The ability to defer defecation improved in all but
one patient in whom it remained unchanged. The median
number of urgency episodes per week decreased from 9
(range, 2–96) to 4 (range, 0–28) (p=0.005).
The evaluation one month after the permanent implanta-
tion showed an improvement of continence in that all thir-
teen patients. The median Wexner score decreased from 14
(range, 6–20) preoperatively to 4 (range, 0–12); p<0.001.
Discussion
Early reports on spinal cord electrostimulation showed
influence on bowel function in patients with severe con-
stipation [12]. Sacral nerve stimulation was first used in
patients with urinary bladder dysfunction [13] and later,
on with a high success rate, in patients with faecal incon-
tinence [14–16]. The minimally invasive two-step proce-
dure of sacral nerve stimulation with percutaneous nerve
evaluation, together with placement of the percutaneous
lead, was performed at our institution without any com-
plications. The use of the new tined lead significantly
increased the technical success rate of screening tests
from 30% to 90% (p=0.005). Similar results are reported
for SNS in bladder dysfunction with improved success
rates from 40% to 80% [9, 17, 18]. However, the learning
curve and better patient selection may have also
increased the implantation rate.
Our results showed a high migration rate for the con-
ventional electrode compared to the tined lead. There are
two main differences in the compared electrodes, which
may explain the results. First, the conventional test wire
is too thin and too flexible for keeping it’s position. It
can easily move and dislodge in the sacral foramen.
Secondly, the anchoring mechanism of the new tined
lead proximal to the electrodes, is an integral part of the
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Table 2 Results of screening tests and permanent stimulation grouped by type of screening electrode
Electrode Electrode dislocations, Screening phase Permanent implantation, 
n of screenings positive n of patients
Conventional 7 of 14 (50%) 4 of 14 (29%) 4
Tined lead 1 of 10 (10%) 9 of 10 (90%) 9
Fig. 1 Tined lead (model 3889, Medtronic) with four electrodes (0-
3) at the distal part, followed by four rings of small anchors to fix
the system in the sacral foramen
lead body, inhibits axial movements of the lead more
effectively than with the conventional electrode, which
is normally fixed by a simple suture only at skin level.
The new tined lead electrode improves patient comfort
during the screening period, as no neutral electrode is nec-
essary. Moreover, the new implantation set decreased the
electrode dislocation rate from 50% with the conventional
test to 10% with the new electrode, p=0.79. As the new
electrode is designed for both screening and permanent
stimulation, an electrode change is no longer necessary at
the time of the implantation of the internal stimulator. If
the results of screening are positive, the lead is already in
the precise place where positive results were obtained.
This avoids false-negative screening tests and other fail-
ures after permanent implantation.
Another major advantage of the new set is the percuta-
neous implantation under local anaesthesia. The use of local
anaesthesia allows the patients to report sensitive responses
during implantation and helps to place the electrode at the
best possible stimulation place. In addition to visualisation
of pelvic floor contraction, patients under local anaesthesia
were able to tell us intraoperatively if the response was sym-
metric and if additional, disturbing sensations in the legs or
toes were present or not. However, we could not show any
statistical benefit in this small patient number, as there were
no differences in the screening success rates comparing
local and general anaesthesia. Despite this, our experience
with awake patients was very convincing. 
The new electrode is more expensive than the conven-
tional one (1600,00 Euro vs. 130,00 Euro, respectively)
and the cost of an unsuccessful screening may be signifi-
cantly higher. Moreover, pelvic fluoroscopy is necessary.
On the other hand, local anaesthesia and a significantly
higher success rate decrease the overall cost.
In conclusion, the use of the new tined lead electrode
designed as permanent electrode allows an optimal screen-
ing with significantly less electrode dislocation. Moreover,
a full implantation under local anaesthesia with patient
guidance is a great advantage. The presented two-stage
procedure under local anaesthesia with the new electrode
should be recommended as standard procedure for SNS,
provided an accurate patient selection is performed.
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